For a while, walking the dog felt hazardous. Earl Vickers was accustomed to taking Molly, his shepherd-boxer-something-else mix, for strolls on the beach or around his neighborhood in Seaside, California. A few years ago, though, he started to experience problems staying upright. “If another dog came toward us, every single time I’d end up on…
By DAVID INTROCASO In late July the UN International Court of Justice (ICJ) announced its long-awaited and highly-anticipated climate advisory opinion. The ICJ ruling represents an historic moment in climate accountability. “Obligations of States in Respect of Climate Change” In a rare unanimous decision, the ICJ opinion concluded “a clean, healthy and sustainable environment” is in…
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
Delaware, Massachusetts roll out behavioral healthcare coordination platforms
With positive Phase 1 results for the metabolic disorder drug MZE782, Maze Therapeutics plans to advance the small molecule to Phase 2 tests in phenylketonuria and chronic kidney disease. Following the data readout, Maze raised $150 million in a private placement. The post Maze Therapeutics Drug Shows Potential to Top Asset Acquired by Otsuka for…
Healthcare groups are pushing back on CMS’ proposed physician fee schedule for next year, raising concerns over payment cuts, administrative burdens and mandatory participation in a new value-based model. Organizations including MGMA, NAACOS and Premier are calling on the agency to revise its plan. The post Industry Groups Warn CMS’ 2026 Fee Schedule Could Undermine…
Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility. The post How Pharma Marketers Can Prepare for Trump’s 200% Tariff Threat appeared first on MedCity News.